EastWest Bioscience (EAST:TSXV) is a vertically integrated wellness company with a multitude of business units that allow for a seed-to-sale supply chain management. We source our raw material, process, manufacture, test, brand, market, and distribute our products to our customers in Canada, the United States, and beyond.


EastWest Bioscience Business Units

Press Releases

October 22, 2020

EastWest Bioscience Announces the Appointment of Carlo Bevilacqua as President of Sangsters

Penticton, BC / October 21, 2020 / EastWest Bioscience (the “Company” or “EastWest”) (TSX.V: EAST) EastWest is pleased to announce the appointment of Carlo Bevilacqua as […]
June 30, 2020

EastWest Bioscience Reports Third Quarter Fiscal 2020 Financial Results

Key highlights of third quarter of 2020 fiscal year Total expenses for the three months ended were $520,274 as compared to $1,158,648 for the same period […]
June 25, 2020

EastWest Bioscience Announces Closing of Private Placement and Settlement of Debts for Shares

PENTICTON, BC / ACCESSWIRE / June 25, 2020 / EastWest Bioscience (the “Company” or “EastWest“) (TSXV:EAST) is pleased to announce that further to the Company’s press release […]
June 19, 2020

EastWest Bioscience Announces Private Placement

VANCOUVER, BC / ACCESSWIRE / June 18, 2020 / EastWest Bioscience (the “Company” or “EastWest“) (TSXV:EAST) announces that it intends to conduct a private placement financing of […]